E. M. van Duijnhoven

Psychosocial consequences of living kidney donation: a prospective multicentre study on health-related quality of life, donor-recipient relationships and regret.

A. Hoitsma, A. Evers, H. van Middendorp, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression.

B. Wolffenbuttel, M. Christiaans, J. V. van Hooff, 2002, Journal of the American Society of Nephrology : JASN.

Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction.

Bruce H R Wolffenbuttel, B. Wolffenbuttel, M. Christiaans, 2002, Journal of the American Society of Nephrology : JASN.

Evaluating mechanisms of post-transplant diabetes mellitus.

M. Christiaans, J. V. van Hooff, E. M. van Duijnhoven, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Tacrolimus and posttransplant diabetes mellitus in renal transplantation.

M. Christiaans, J. V. van Hooff, E. V. van Duijnhoven, 2005, Transplantation.

Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study

M. Christiaans, R. V. van Suylen, J. V. van Hooff, 2002, Transplantation.

Development and Validation of a Multiplex Non-HLA Antibody Assay for the Screening of Kidney Transplant Recipients

M. Bots, P. V. D. van der Boog, M. Christiaans, 2018, Front. Immunol..

Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure.

M. Bots, P. V. D. van der Boog, M. Christiaans, 2018, Journal of the American Society of Nephrology : JASN.

Determination of the clinical relevance of donor epitope‐specific HLA‐antibodies in kidney transplantation

P. V. D. van der Boog, M. Christiaans, J. D. de Fijter, 2024, HLA.